These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 406040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M, McGarry R, Kupelnick B.
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
    Tzai TS, Chow NH, Lin JS, Yang WH, Tong YC.
    Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection: a combined analysis of trials by the Japanese Urological Cancer Research Group using smoothed hazard function.
    Hinotsu S, Akaza H, Ohashi Y, Kotake T.
    Cancer; 1999 Nov 01; 86(9):1818-26. PubMed ID: 10547556
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Chemoprophylaxis of superficial tumors of the bladder with thiotepa: long-term results].
    Durán R, Reina GR, Hontoria JM, Merino C, Olivier C, Carballido J.
    Actas Urol Esp; 1989 Nov 01; 13(1):19-23. PubMed ID: 2496583
    [Abstract] [Full Text] [Related]

  • 14. Use of intravesical thiotepa in superficial bladder tumours.
    Kulkarni JN, Kamat MR, Juvekar RL.
    Indian J Cancer; 1981 Sep 01; 18(3):222-4. PubMed ID: 6796504
    [No Abstract] [Full Text] [Related]

  • 15. Proceedings: Adjuvant intravesical thiotepa and bladder tumour recurrence.
    Boyd PJ, Burnand KG.
    Br J Surg; 1975 Feb 01; 62(2):162. PubMed ID: 803851
    [No Abstract] [Full Text] [Related]

  • 16. A trial of prophylactic thiotepa or mitomycin C intravesical therapy in patients with recurrent or multiple superficial bladder cancers.
    Flanigan RC, Ellison MF, Butler KM, Gomella LG, McRoberts JW.
    J Urol; 1986 Jul 01; 136(1):35-7. PubMed ID: 3086575
    [Abstract] [Full Text] [Related]

  • 17. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP.
    Semin Urol Oncol; 1996 Feb 01; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [Abstract] [Full Text] [Related]

  • 18. [Superficial bladder tumors. Preliminary results of a prospective study comparing endovesical BCG, adriamycin and thio-tepa].
    Martínez-Piñeiro JA, de la Peña J, Hidalgo L, Cisneros J, Jiménez León J, Machuca J, Perdices C.
    Arch Esp Urol; 1985 Feb 01; 38(6):545-53. PubMed ID: 3938633
    [No Abstract] [Full Text] [Related]

  • 19. First-line chemotherapy of superficial bladder cancer: mitomycin vs thiotepa.
    Heney NM.
    Urology; 1985 Oct 01; 26(4 Suppl):27-9. PubMed ID: 3931325
    [Abstract] [Full Text] [Related]

  • 20. Resume of selected studies of the National Bladder Cancer Collaborative Group A and new protocols.
    Prout GR, Kopp J.
    Prog Clin Biol Res; 1984 Oct 01; 162B():397-427. PubMed ID: 6438644
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.